Role of megalin, a proximal tubular endocytic receptor, in the pathogenesis of diabetic and metabolic syndrome-related nephropathies: Protein metabolic overload hypothesis

Nephrology

Volumn 10, Issue SUPPL. 2, 2005, Pages

  Saito, Akihiko ^a   Takeda, Tetsuro ^a   Hama, Hitomi ^a   Oyama, Yuko ^a   Hosaka, Kiyoko ^a   Tanuma, Atsuhito ^a   Kaseda, Ryohei ^a   Ueno, Mitsuhiro ^a   Nishi, Shinichi ^b   Ogasawara, Shinya ^c   Gondaira, Fumio ^c   Suzuki, Yoshiki ^d   Gejyo, Fumitake ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

^c DENKA COMPANY LIMITED   (Japan)

^d NIIGATA UNIVERSITY   (Japan)

Author keywords

Diabetic nephropathy; Megalin; Metabolic syndrome related nephropathy; Protein metabolic overload; Proximal tubule cell

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ANGIOTENSIN; FATTY ACID BINDING PROTEIN; INSULIN; LEPTIN; MEGALIN;

ANGIOTENSIN BLOOD LEVEL; CLINICAL ARTICLE; CONFERENCE PAPER; DIABETIC NEPHROPATHY; FEEDBACK SYSTEM; FEMALE; GLOMERULUS FILTRATION; HUMAN; HYPERTENSION; HYPOXIA; INSULIN BLOOD LEVEL; KIDNEY DISEASE; KIDNEY HYPERTROPHY; KIDNEY ISCHEMIA; KIDNEY METABOLISM; KIDNEY PROXIMAL TUBULE; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN METABOLISM; PROTEIN TRANSPORT; RISK ASSESSMENT; SIGNAL TRANSDUCTION; SLEEP APNEA SYNDROME; SODIUM ABSORPTION;

DIABETIC NEUROPATHIES; ENDOCYTOSIS; HUMANS; KIDNEY DISEASES; KIDNEY TUBULES, PROXIMAL; LDL-RECEPTOR RELATED PROTEIN 2; METABOLIC SYNDROME X;

EID: 28544437241     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2005.00453.x     Document Type: Conference Paper

References (53)

1. Saito A, Pietromonaco S, Loo AK, Farquhar MG. Complete cloning and sequencing of rat gp330/megalin', a distinctive member of the low density lipoprotein receptor gene family. Proc. Natl. Acad. Sci. USA 1994; 91: 9725-9.
2. Kerjaschki D, Farquhar MG. The pathogenic antigen of Heymann nephritis is a membrane glycoprotein of the renal proximal tubule brush border. Proc. Natl. Acad. Sci. USA 1982; 79: 5557-61.
3. Farquhar MG, Saito A, Kerjaschki D, Orlando RA. The Heymann nephritis antigenic complex: megalin (gp330) and RAP. J. Am. Soc. Nephrol. 1995; 6: 35-47.
4. Christensen EI, Birn H. Megalin and cubilin: multifunctional endocytic receptors. Nat. Rev. Mol. Cell. Biol. 2002; 3: 256-66.
5. Marino M, Zheng G, Chiovato L et al. Role of megalin (gp330) in transcytosis of thyroglobulin by thyroid cells. A novel function in the control of thyroid hormone release. J. Biol. Chem. 2000; 275: 7125-37.
6. Marino M, Andrews D, Brown D, McCluskey RT. Transcytosis of retinol-binding protein across renal proximal tubule cells after megalin (gp 330)-mediated endocytosis. J. Am. Soc. Nephrol. 2001; 12: 637-48.
7. Biemesderfer D, Nagy T, DeGray B, Aronson PS. Specific association of megalin and the Na+/H+ exchanger isoform NHE3 in the proximal tubule. J. Biol. Chem. 1999; 274: 17518-24.
8. Biemesderfer D, DeGray B, Aronson PS. Active (9.6 s) and inactive (21 s) oligomers of NHE3 in microdomains of the renal brush border. J. Biol. Chem. 2001; 276: 10161-7.
9. Oleinikov AV, Zhao J, Makker SP. Cytosolic adaptor protein Dab2 is an intracellular ligand of endocytic receptor gp600/megalin. Biochem. J. 2000; 347: 613-21.
10. Rader K, Orlando RA, Lou X, Farquhar MG. Characterization of ANKRA, a novel ankyrin repeat protein that interacts with the cytoplasmic domain of megalin. J. Am. Soc. Nephrol. 2000; 11: 2167-78.
11. Patrie KM, Drescher AJ, Goyal M, Wiggins RC, Margolis B. The membrane-associated guanylate kinase protein MAGI-1 binds megalin and is present in glomerular podocytes. J. Am. Soc. Nephrol. 2001; 12: 667-77.
12. Lou X, McQuistan T, Orlando RA, Farquhar MG. GAIP, GIPC and Galphai3 are concentrated in endocytic compartments of proximal tubule cells: putative role in regulating megalin's function. J. Am. Soc. Nephrol. 2002; 13: 918-27.
13. Petersen HH, Hilpert J, Militz D et al. Functional interaction of megalin with the megalinbinding protein (MegBP), a novel tetratrico peptide repeat-containing adaptor molecule. J. Cell Sci. 2003; 116: 453-61.
14. Nagai M, Meerloo T, Takeda T, Farquhar MG. The adaptor protein ARH escorts megalin to and through endosomes. Mol. Biol. Cell. 2003; 14: 4984-96.
15. Fasshauer M, Paschke R. Regulation of adipocytokines and insulin resistance. Diabetologia 2003; 46: 1594-603.
16. Ouchi N, Kihara S, Funahashi T, Matsuzawa Y, Walsh K. Obesity, adiponectin and vascular inflammatory disease. Curr. Opin. Lipidol. 2003; 14: 561-6.
17. Chen J, Muntner P, Hamm LL et al. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann. Intern. Med. 2004; 14: 167-74.
18. Bagby SP. Obesity-initiated metabolic syndrome and the kidney: a recipe for chronic kidney disease? J. Am. Soc. Nephrol. 2004; 15: 2775-91.
19. Kambham N, Markowitz GS, Valeri AM, Lin J, D'Agati VD. Obesity-related glomerulopathy: anemerging epidemic. Kidney Int. 2001; 59: 1498-509.
20. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 2001; 285: 2486-97.
21. Examination Committee of Criteria for 'Obesity Disease' in Japan. Japan Society for the Study of Obesity. New criteria for 'obesity disease' in Japan. Circ. J. 2002; 66: 987-92.
22. Vallon V, Blantz RC, Thomson S. Glomerular hyperfiltration and the salt paradox in early type 1 diabetes mellitus: a tubulo-centric view. J. Am. Soc. Nephrol. 2003; 14: 530-7.
23. Hall JE, Henegar JR, Dwyer TM et al. Is obesity a major cause of chronic kidney disease? Adv. Ren. Replace. Ther. 2004; 11: 41-54.
24. Thomson SC, Vallon V, Blantz RC. Kidney function in early diabetes: the tubular hypothesis of glomerular filtration. Am. J. Physiol. Renal Physiol. 2004; 286: F8-15.
25. Gugliucci A, Bendayan M. Renal fate of circulating advanced glycated end products (AGE): evidence for reabsorption and catabolism of AGE-peptides by renal proximal tubular cells. Diabetulogia 1996; 39: 149-60.
26. Miyata T, Ueda Y, Horie K et al. Renal catabolism of advanced glycation end products: the fate of pentosidine. Kidney Int. 1998; 53: 416-22.
27. Yamagishi S, Inagaki Y, Okamoto T, Amano S, Koga K, Takeuchi M. Advanced glycation end products inhibit de novo protein synthesis and induce TGF-beta overexpression in proximal tubular cells. Kidney Int. 2003; 63: 464-73.
28. Sebekova K, Schinzel R, Ling H et al. Advanced glycated albumin impairs protein degradation in the kidney proximal tubules cell line LLC-PK1. Cell. Mol. Biol. 1998; 44: 1051-60.
29. Saito A, Nagai R, Tanuma A et al. Role of megalin in endocytosis of advanced glycation end products: implications for a novel protein binding to both megalin and advanced glycation end products. J. Am. Soc. Nephrol. 2003; 14: 1123-31.
30. Zimmerman AW, Veerkamp JH. New insights into the structure and function of fatty acid-binding proteins. Cell. Mol. Life Sci. 2002; 59: 1096-116.
31. Pelsers MM, Morovat A, Alexander GJ, Hermens WT, Trull AK, Glatz JF. Liver fatty acid-binding protein as a sensitive serum marker of acute hepatocellular damage in liver transplant recipients. Clin. Chem. 2002; 48: 2055-7.
32. Oyama Y, Takeda T, Hama H et al. Evidence for megalin-mediated proximal tubular uptake of L-FABP, a carrier of potentially nephrotoxic molecules. Lab. Invest. 2005.
33. Wolf G, Neilson EG. Angiotensin II as a renal growth factor. J. Am. Soc. Nephrol. 1993; 3: 1531-40.
34. Burns KD, Li N. The role of angiotensin II-stimulated renal tubular transport in hypertension. Curr. Hypertens. Rep. 2003; 5: 165-71.
35. Engeli S, Schling P, Gorzelniak K et al. The adipose-tissue renin-angiotensin-aldosterone system: role in the metabolic syndrome? Int. J. Biochem. Cell Biol. 2003; 35: 807-25.
36. Zhuo JL, Imig JD, Hammond TG, Orengo S, Benes E, Navar LG. Ang II accumulation in rat renal endosomes during Ang II-induced hypertension: role of AT (1) receptor. Hypertension 2002; 39: 116-21.
37. Gonzalez-Villalobos R, Klassen RB, Allen PL, Navar LG, Hammond TG. Megalin binds and internalizes angiotensin II. Am. J. Physiol. Renal Physiol. 2005; 288: F420-7.
38. Orlando RA, Rader K, Authier F et al. Megalin is an endocytic receptor for insulin. J. Am. Soc. Nephrol. 1998; 9: 1759-66.
39. Klisic J, Hu MC, Nief V et al. Insulin activates Na(+)/H(+) exchanger 3: biphasic response and glucocorticoid dependence. Am. J. Physiol. Renal Physiol. 2002; 283: F532-9.
40. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372: 425-32.
41. Pelleymounter MA, Cullen MJ, Baker MB et al. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995; 269: 540-3.
42. Halaas JL, Gajiwala KS, Maffei M et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995; 269: 543-6.
43. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 1995; 269: 546-9.
44. Considine RV, Sinha MK, Heiman ML et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N. Engl. J. Med. 1996; 334: 292-5.
45. Hama H, Saito A, Takeda T et al. Evidence indicating that renal tubular metabolism of leptin is mediated by megalin but not by the leptin receptors. Endocrinology 2004; 145: 3935-40.
46. Holt S, Moore K. Pathogenesis of renal failure in rhabdomyolysis: the role of myoglobin. Exp. Nephrol. 2000; 8: 72-6.
47. Gburek J, Birn H, Verroust PJ et al. Renal uptake of myoglobin is mediated by the endocytic receptors megalin and cubilin. Am. J. Physioi. Renal Physiol. 2003; 285: F451-8.
48. Eckardt KU, Rosenberger C, Jurgensen JS, Wiesener MS. Role of hypoxia in the pathogenesis of renal disease. Blood Purif. 2003; 21: 253-7.
49. Nangaku M. Hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure. Nephron Exp. Nephrol. 2004: 98: e8-12.
50. Kinebuchi S, Kazama JJ, Satoh M et al. Short-term use of continuous positive airway pressure ameliorates glomerular hyperfiltration in patients with obstructive sleep apnoea syndrome. Clin. Sci. (Lond.) 2004; 107: 317-22.
51. Keller G, Zimmer G, Mall G, Ritz E, Amann K. Nephron number in patients with primary hypertension. N. Engi. j. Med. 2003; 348: 101-8.
52. Praga M, Hernandez E, Herrero JC et al. Influence of obesity on the appearance of proteinuria and renal insufficiency after unilateral nephrectomy. Kidney Int. 2000; 58: 2111-8.
53. Lackland DT, Bendall HE, Osmond C, Egan BM, Barker DJ. Low birth weights contribute to high rates of early-onset chronic renal failure in the Southeastern United States. Arch. Intern. Med. 2000; 160: 1472-6. S32-S36